Zechmann, Christian M <br/><br/>
Radiation dosimetry and first therapy results with a (124)I/ (131)I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy.  [electronic resource] 

 -  European journal of nuclear medicine and molecular imaging  Jul 2014 
 - 1280-92 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1619-7089 
<br/><br/><label>Standard No.: </label>10.1007/s00259-014-2713-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antigens, Surface--metabolism<br/>Glutamate Carboxypeptidase II--metabolism<br/>Glutamates--adverse effects<br/>Humans<br/>Iodine Radioisotopes--therapeutic use<br/>Male<br/>Middle Aged<br/>Molecular Targeted Therapy--adverse effects<br/>Neoplasm Metastasis<br/>Organs at Risk--radiation effects<br/>Positron-Emission Tomography<br/>Prostatic Neoplasms--diagnostic imaging<br/>Radiometry<br/>Radiopharmaceuticals--adverse effects<br/>Radiotherapy Dosage<br/>Safety<br/>Tomography, X-Ray Computed<br/>Treatment Outcome<br/>Urea--adverse effects